OncoDNA
PrivateLast Round
Series C
Jul 5, 2023
Total Funding Raised
$35.77M
Momentum
Quiet
No recent growth signals
Company Overview
OncoDNA is a biotechnology company founded in 2012 that provides genomic and theranostic testing services and software to aid oncologists in making personalized treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoDNA Comps
Public and private peers based on sector, stage, and business model.
OncoDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 5, 2023 | ||||
| Series B | Feb 14, 2020 | ||||
| Series A | Sep 2, 2016 |
Key People
Founding team and executive leadership
OncoDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ackermans & van Haaren | Series B, Series C, Series A |
| Verve Ventures | Series B |
| Inventures | Series A, Series B |
| Société Régionale d'Investissement de Wallonie | Series A, Series B |
| Wallonie Entreprendre | Series C |
| Vesalius Biocapital Partners | Series C, Series B |
| Sambrinvest | Series A, Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Upcoming launch of 'fragmentomics' liquid biopsy assay in March 2026.
- Jan 26, 2026
Announced upcoming commercial launch of OncoXPLORE.
OncoDNA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoDNA's valuation, stock price, and market status.
